New Hampshire is facing a growing number of Hepatitis C incidences relating to the state’s recent opioid outbreak. The practice of sharing needles among intravenous drug users has led many providers in the state, including gastroenterologists, to see a larger than normal number of cases of Hepatitis C, bacterial endocarditis and other severe infections among this population. Hepatitis C is a curable disease and treatments can cost up to $100,000 per patient. Due to the prevention possibilities regarding Hepatitis C, and its potential correlation with HIV among drug users, New Hampshire officials are considering steps to assist this group with treatment.

Sources